VIH

Based on the provided articles, "VIH" is likely the French abbreviation for HIV (Virus de l'Immunodéficience Humaine). The articles discuss advancements in HIV prevention and treatment, specifically highlighting a new injectable PrEP (pre-exposure prophylaxis) administered every two months as a more convenient alternative to daily pills. This development is newsworthy due to its potential to improve adherence and accessibility to preventative care. The articles also mention Sidaction, a French fundraising event for AIDS research, and concerns about declining international funding for HIV/AIDS programs. The availability of injectable PrEP in France and the ongoing Sidaction campaign underscore the continued relevance of VIH research and prevention efforts in the face of funding challenges and the ongoing global fight against HIV/AIDS.